Lakefront Biotherapeutics
LKFT
#5107
Rank
โ‚น176.03 B
Marketcap
โ‚น2,688
Share price
-1.00%
Change (1 day)
N/A
Change (1 year)

Revenue for Lakefront Biotherapeutics (LKFT)

Revenue in 2026 (TTM): โ‚น109.71 Billion

According to Lakefront Biotherapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น118.40 Billion. In 2025 the company made a revenue of โ‚น116.68 Billion an increase over the revenue in the year 2024 that were of โ‚น25.40 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lakefront Biotherapeutics from 2015 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น109.71 B-5.97%
2025 โ‚น116.68 B359.21%
2024 โ‚น25.40 B147.77%
2023 โ‚น10.25 B-76.64%
2022 โ‚น43.89 B4.8%
2021 โ‚น41.88 B5.34%
2020 โ‚น39.76 B-39.94%
2019 โ‚น66.20 B181.28%
2018 โ‚น23.53 B152.86%
2017 โ‚น9.30 B-1.85%
2016 โ‚น9.48 B229.26%
2015 โ‚น2.88 B